Securities Code: 002432 Securities Abbreviation: Anji Medical Announcement No.: 2026-012
Tianjin Anji Medical Electronics Co., Ltd. Resolution Announcement of the Third Meeting of the Seventh Board of Directors
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Tianjin Anji Medical Electronics Co., Ltd. (hereinafter referred to as the "Company" or "this Company") issued a notice on April 21, 2026, via communication to convene the third meeting of the seventh Board of Directors. The meeting was held on April 24, 2026, in the Company's conference room through a combination of on-site and remote voting. The meeting was presided over by Mr. Liu Yi, Chairman of the Company. Six directors were supposed to attend, and six directors actually attended. Senior management personnel of the Company attended the meeting, which complied with the provisions of the "Company Law" and the "Articles of Association." The meeting passed the following proposal by voting:
- The meeting, with 5 votes in favor, 0 votes against, and 0 abstentions, deliberated and approved the "Proposal on Participating in Investment Fund Subscription."
The Company intends to subscribe for a portion of Tianjin Haitang Tonghui Venture Capital Partnership (Limited Partnership) with its own funds of RMB 103 million. The total scale of this fund is RMB 412.01 million (subject to the actual amount raised). The general partner and manager is Tianjin Haitang Venture Capital Management Center (Limited Partnership). The Company intends to act as one of the limited partners (LP) to conduct financial investment. This investment will help the Company seize market opportunities in the field of technological innovation, leverage the advantages of the fund's professional team and project resources and channels, broaden the Company's investment channels, improve the efficiency of the Company's asset allocation business, and further enhance the Company's overall competitiveness and profitability.